Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Infections in Old Age”

386 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 386 results

Post-approval studies (Phase 4)Study completedNCT01827462
What this trial is testing

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Who this might be right for
Influenza
Stanford University 136
Large-scale testing (Phase 3)WithdrawnNCT04938323
What this trial is testing

Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly

Who this might be right for
Acute Respiratory Infection
Harvard Medical School (HMS and HSDM)
Large-scale testing (Phase 3)UnknownNCT05911061
What this trial is testing

A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 4,950
Post-approval studies (Phase 4)Study completedNCT02878031
What this trial is testing

Community Case Management of Chest Indrawing Pneumonia

Who this might be right for
Pneumonia
Malaria Consortium 191
Post-approval studies (Phase 4)Study completedNCT01752881
What this trial is testing

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects

Who this might be right for
Influenza
Adimmune Corporation 130
Testing effectiveness (Phase 2)Study completedNCT03803202
What this trial is testing

A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine

Who this might be right for
Pneumonia, BacterialHealthy VolunteersPneumococcal Disease
GlaxoSmithKline 630
Not applicableNot Yet RecruitingNCT06747325
What this trial is testing

Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia (CAP)
Henan University of Traditional Chinese Medicine 120
Testing effectiveness (Phase 2)Study completedNCT00775450
What this trial is testing

Influenza Vaccine Revaccination in Ambulatory Elderly Subjects

Who this might be right for
InfluenzaOrthomyxovirus InfectionMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 807
Not applicableLooking for participantsNCT07463443
What this trial is testing

Effectiveness of Chatbot for Improving Caregiving Outcomes in Primary Caregivers of Geriatric Pneumonia Patients: A Study on Knowledge, Attitude and Practice.

Who this might be right for
PneumoniaFamily CaregiversKnowledge, Attitudes, Practice+2 more
Taipei Veterans General Hospital, Taiwan 150
Large-scale testing (Phase 3)Study completedNCT00772889
What this trial is testing

Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly

Who this might be right for
Influenza
GlaxoSmithKline 971
Not applicableStudy completedNCT04713735
What this trial is testing

Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections

Who this might be right for
Immune Health
Mead Johnson Nutrition 76
Not applicableStudy completedNCT01006330
What this trial is testing

Dysphagia in Elderly Medical Patients

Who this might be right for
Deglutition DisordersImpaired CognitionPhysical Activity+2 more
Herlev Hospital 110
Testing effectiveness (Phase 2)WithdrawnNCT04718467
What this trial is testing

Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention
Not applicableStudy completedNCT05706935
What this trial is testing

MeMed BV® Test Evaluation in Adult Emergency Department Patients

Who this might be right for
Respiratory InfectionRespiratory Infections in Old AgeRespiratory Infection Virus+1 more
University of Wisconsin, Madison 111
Testing effectiveness (Phase 2)UnknownNCT05365724
What this trial is testing

Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above

Who this might be right for
COVID-19
China National Biotec Group Company Limited 280
Testing effectiveness (Phase 2)Study completedNCT00230750
What this trial is testing

Inactivated Influenza A/H5N1 Vaccine in the Elderly

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 261
Not applicableStudy completedNCT01459276
What this trial is testing

Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 1,206
Large-scale testing (Phase 3)Study completedNCT00529516
What this trial is testing

Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

Who this might be right for
Influenza
GlaxoSmithKline 1,252
Large-scale testing (Phase 3)Study completedNCT02107807
What this trial is testing

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Who this might be right for
Influenza, HumanFlu, HumanFlu, Avian+2 more
Seqirus 539
Testing effectiveness (Phase 2)Study completedNCT00841646
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects

Who this might be right for
Prepandemic Influenza Vaccine
Novartis Vaccines 343
Next Page